AI Science Tracker
EN

Predicting Early Outcomes of Prostatic Artery Embolization Using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Machine Learning Study

Molecular and Interventional Radiology · 28 May 2025 · medicine

Discovery

Predicting Early Outcomes of Prostatic Artery Embolization Using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Machine Learning Study

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: A TabPFN model predicted 7-week symptom-score response after prostatic-artery embolization in 109 retrospective patients (AUROC 0.821) under repeated internal cross-validation; this is a narrow short-term prediction result, not evidence of treatment benefit or external validity.

Technology: TabPFN learns from clinical and procedural features to classify six-week IPSS response

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
TabPFN learns from clinical and procedural features to classify six-week IPSS response
Limitation / still unknown
The findings are limited to the reported dataset, experimental setup and validation described in the source; broader generalization and real-world benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/40506923 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12154727/ · https://pubmed.ncbi.nlm.nih.gov/40506923/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.